Cancer: Metformin reduces expression of cancer gene
Nature Communications
2012년5월30일
Metformin, a drug used to treat diabetes, alters the microRNA system and downregulates the expression of a cancer gene, reports a study published in Nature Communications this week. These findings provide an explanation for how metformin treatment may reduce cancer incidence in diabetes patients.
Metformin reduces insulin resistance and lowers blood glucose levels and multiple studies have shown that its use reduces the incidence of cancer. The way in which it succeeds is doing so, however, has remained unknown. Giovanni Blandino and colleagues showed that treatment of mice with metformin reduced tumour formation and can also reduce the size of pre-formed tumours. They found that in cells in culture metformin altered the pattern of expression of microRNAs, which modulate the expression genes. When they further analysed the genes that were altered in expression in cultured cells they found that the oncogene c-Myc was reduced in expression. These finding suggest that the anti-cancer effect of metformin in cells in culture results from the alteration of the production of microRNAs, which in turn modifies the expression of genes, including oncogenes.
doi: 10.1038/ncomms1859
리서치 하이라이트
-
6월24일
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
6월23일
Scientific community: Women credited less than men in scientific paper authorshipNature
-
6월17일
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
6월16일
An exercise-inducible molecule that suppresses appetiteNature
-
6월16일
Cancer: Signatures of structural genomic variation in cancerNature
-
6월10일
Animals: Genetic clues to how dogs became man’s best friendsScientific Reports